For Revolve Group Inc (NYSE:RVLV), B of A Securities downgraded the previous rating of Buy to Underperform. For the first quarter, Revolve Gr had an EPS of $0.30, compared to year-ago quarter EPS of $0.30. The current stock performance of Revolve Gr shows a 52-week-high of $63.92 and a 52-week-low of $24.10. Moreover, at the end of the last trading period, the closing price was at $27.48.

According to Stifel, the prior rating for Infrastructure and Energy Alternatives Inc (NASDAQ:IEA) was changed from Buy to Hold. For the first quarter, Infrastructure and Energy had an EPS of $0.56, compared to year-ago quarter EPS of $0.91. The current stock performance of Infrastructure and Energy shows a 52-week-high of $14.45 and a 52-week-low of $6.38. Moreover, at the end of the last trading period, the closing price was at $13.75.

According to DA Davidson, the prior rating for Infrastructure and Energy Alternatives Inc (NASDAQ:IEA) was changed from Buy to Neutral. For the first quarter, Infrastructure and Energy had an EPS of $0.56, compared to year-ago quarter EPS of $0.91. The stock has a 52-week-high of $14.45 and a 52-week-low of $6.38. At the end of the last trading period, Infrastructure and Energy closed at $13.75.

Roth Capital downgraded the previous rating for Vista Outdoor Inc (NYSE:VSTO) from Buy to Neutral. Vista Outdoor earned $2.04 in the fourth quarter, compared to $1.02 in the year-ago quarter. The current stock performance of Vista Outdoor shows a 52-week-high of $52.69 and a 52-week-low of $25.68. Moreover, at the end of the last trading period, the closing price was at $29.60.

For VistaGen Therapeutics Inc (NASDAQ:VTGN), Maxim Group downgraded the previous rating of Buy to Hold. In the fourth quarter, VistaGen Therapeutics showed an EPS of $0.09, compared to $0.30 from the year-ago quarter. The current stock performance of VistaGen Therapeutics shows a 52-week-high of $2.11 and a 52-week-low of $0.14. Moreover, at the end of the last trading period, the closing price was at $0.18.

Seaport Global downgraded the previous rating for NextEra Energy Inc (NYSE:NEE) from Buy to Neutral. In the second quarter, NextEra Energy showed an EPS of $0.81, compared to $0.71 from the year-ago quarter. The current stock performance of NextEra Energy shows a 52-week-high of $93.65 and a 52-week-low of $67.22. Moreover, at the end of the last trading period, the closing price was at $80.98.

For American Eagle Outfitters Inc (NYSE:AEO), B of A Securities downgraded the previous rating of Neutral to Underperform. In the first quarter, American Eagle Outfitters showed an EPS of $0.16, compared to $0.48 from the year-ago quarter. The stock has a 52-week-high of $26.08 and a 52-week-low of $10.98. At the end of the last trading period, American Eagle Outfitters closed at $12.03.

According to Wolfe Research, the prior rating for Roku Inc (NASDAQ:ROKU) was changed from Peer Perform to Underperform. In the first quarter, Roku showed an EPS of $0.19, compared to $0.54 from the year-ago quarter. The current stock performance of Roku shows a 52-week-high of $238.36 and a 52-week-low of $72.63. Moreover, at the end of the last trading period, the closing price was at $86.71.

According to Compass Point, the prior rating for HomeTrust Bancshares Inc (NASDAQ:HTBI) was changed from Buy to Neutral. HomeTrust Bancshares earned $0.51 in the third quarter, compared to $0.48 in the year-ago quarter. At the moment, the stock has a 52-week-high of $32.60 and a 52-week-low of $24.06. HomeTrust Bancshares closed at $25.35 at the end of the last trading period.

For Paramount Global (NASDAQ:PARA), Goldman Sachs downgraded the previous rating of Buy to Sell. For the first quarter, Paramount Global had an EPS of $0.60, compared to year-ago quarter EPS of $1.52. The current stock performance of Paramount Global shows a 52-week-high of $39.21 and a 52-week-low of $23.68. Moreover, at the end of the last trading period, the closing price was at $25.34.

For MicroStrategy Inc (NASDAQ:MSTR), Jefferies downgraded the previous rating of Hold to Underperform. MicroStrategy earned $10.42 in the first quarter, compared to $1.54 in the year-ago quarter. The current stock performance of MicroStrategy shows a 52-week-high of $576.26 and a 52-week-low of $134.09. Moreover, at the end of the last trading period, the closing price was at $265.86.

Credit Suisse downgraded the previous rating for Traeger Inc (NYSE:COOK) from Outperform to Neutral. Traeger earned $0.17 in the first quarter, compared to $0.41 in the year-ago quarter. The current stock performance of Traeger shows a 52-week-high of $12.38 and a 52-week-low of $3.22. Moreover, at the end of the last trading period, the closing price was at $3.27.

Spartan Securities Group initiated coverage on Society Pass Inc (NASDAQ:SOPA) with a Buy rating. The price target for Society Pass is set to $8.00. Society Pass earned $0.30 in the first quarter, compared to $0.15 in the year-ago quarter. The current stock performance of Society Pass shows a 52-week-high of $12.20 and a 52-week-low of $1.49. Moreover, at the end of the last trading period, the closing price was at $1.86.

With a Buy rating, Lake Street initiated coverage on BlackSky Technology Inc (NYSE:BKSY). The price target seems to have been set at $6.00 for BlackSky Technology. For the first quarter, BlackSky Technology had an EPS of $0.17, compared to year-ago quarter EPS of $0.70. The stock has a 52-week-high of $5.01 and a 52-week-low of $1.00. At the end of the last trading period, BlackSky Technology closed at $2.18.

With a Buy rating, Maxim Group initiated coverage on StealthGas Inc (NASDAQ:GASS). The price target seems to have been set at $7.00 for StealthGas. In the first quarter, StealthGas showed an EPS of $0.23, compared to $0.02 from the year-ago quarter. The current stock performance of StealthGas shows a 52-week-high of $4.18 and a 52-week-low of $1.91. Moreover, at the end of the last trading period, the closing price was at $2.61.

RBC Capital initiated coverage on Bausch & Lomb Corp (NYSE:BLCO) with an Outperform rating. The price target for Bausch & Lomb is set to $22.00. For the first quarter, Bausch & Lomb had an EPS of $0.24, compared to year-ago quarter EPS of $0.27. The current stock performance of Bausch & Lomb shows a 52-week-high of $20.20 and a 52-week-low of $13.17. Moreover, at the end of the last trading period, the closing price was at $16.09.

JMP Securities initiated coverage on Century Casinos Inc (NASDAQ:CNTY) with a Market Outperform rating. The price target for Century Casinos is set to $15.00. For the first quarter, Century Casinos had an EPS of $0.01, compared to year-ago quarter EPS of $0.05. The current stock performance of Century Casinos shows a 52-week-high of $13.55 and a 52-week-low of $6.69. Moreover, at the end of the last trading period, the closing price was at $8.03.

BTIG initiated coverage on Keros Therapeutics Inc (NASDAQ:KROS) with a Buy rating. The price target for Keros Therapeutics is set to $80.00. Keros Therapeutics earned $1.01 in the first quarter, compared to $0.68 in the year-ago quarter. At the moment, the stock has a 52-week-high of $68.29 and a 52-week-low of $24.38. Keros Therapeutics closed at $28.53 at the end of the last trading period.

BMO Capital initiated coverage on The Howard Hughes Corp (NYSE:HHC) with an Outperform rating. The price target for Howard Hughes is set to $90.00. Howard Hughes earned $0.04 in the first quarter, compared to $0.56 in the year-ago quarter. The stock has a 52-week-high of $105.51 and a 52-week-low of $60.04. At the end of the last trading period, Howard Hughes closed at $69.82.

Stifel initiated coverage on Sight Sciences Inc (NASDAQ:SGHT) with a Hold rating. The price target for Sight Sciences is set to $10.00. Sight Sciences earned $0.49 in the first quarter, compared to $1.29 in the year-ago quarter. The stock has a 52-week-high of $18.40 and a 52-week-low of $6.25. At the end of the last trading period, Sight Sciences closed at $10.18.

With an Outperform rating, Wedbush initiated coverage on Vor Biopharma Inc (NASDAQ:VOR). The price target seems to have been set at $18.00 for Vor Biopharma. In the first quarter, Vor Biopharma showed an EPS of $0.61, compared to $0.67 from the year-ago quarter. At the moment, the stock has a 52-week-high of $12.73 and a 52-week-low of $3.83. Vor Biopharma closed at $4.53 at the end of the last trading period.